AU499459B2 - Antioboitics - Google Patents

Antioboitics

Info

Publication number
AU499459B2
AU499459B2 AU79599/75A AU7959975A AU499459B2 AU 499459 B2 AU499459 B2 AU 499459B2 AU 79599/75 A AU79599/75 A AU 79599/75A AU 7959975 A AU7959975 A AU 7959975A AU 499459 B2 AU499459 B2 AU 499459B2
Authority
AU
Australia
Prior art keywords
antioboitics
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU79599/75A
Other languages
English (en)
Other versions
AU7959975A (en
Inventor
Dennis Butterworth
Martin Cole
John Dick Hood
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Publication of AU7959975A publication Critical patent/AU7959975A/en
Application granted granted Critical
Publication of AU499459B2 publication Critical patent/AU499459B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07G—COMPOUNDS OF UNKNOWN CONSTITUTION
    • C07G11/00—Antibiotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/182—Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system
    • C12P17/184—Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system containing a beta-lactam ring, e.g. thienamycin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU79599/75A 1974-03-28 1975-03-27 Antioboitics Ceased AU499459B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB13856/74A GB1489235A (en) 1974-03-28 1974-03-28 Antibiotics
GB13856/74 1974-03-28
AU45499/79A AU530414B2 (en) 1974-03-28 1979-03-29 Antibiotic mm13902

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU45499/79A Division AU530414B2 (en) 1974-03-28 1979-03-29 Antibiotic mm13902

Publications (2)

Publication Number Publication Date
AU7959975A AU7959975A (en) 1976-09-30
AU499459B2 true AU499459B2 (en) 1979-04-26

Family

ID=25627229

Family Applications (2)

Application Number Title Priority Date Filing Date
AU79599/75A Ceased AU499459B2 (en) 1974-03-28 1975-03-27 Antioboitics
AU45499/79A Ceased AU530414B2 (en) 1974-03-28 1979-03-29 Antibiotic mm13902

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU45499/79A Ceased AU530414B2 (en) 1974-03-28 1979-03-29 Antibiotic mm13902

Country Status (13)

Country Link
JP (1) JPS582675B2 (ja)
AT (1) AT345454B (ja)
AU (2) AU499459B2 (ja)
BE (1) BE827332A (ja)
CA (1) CA1050460A (ja)
CH (1) CH626628A5 (ja)
DE (1) DE2513854C2 (ja)
FR (1) FR2265399B1 (ja)
GB (1) GB1489235A (ja)
LU (1) LU72155A1 (ja)
NL (1) NL7503672A (ja)
OA (1) OA05204A (ja)
SE (1) SE7503536L (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK145504C (da) * 1976-04-28 1983-04-25 Merck & Co Inc Fremgangsmaade til fremstilling af det antibiotiske stof 890a2og/eller det antibiotiske stof 890a5 og farmaceutisk acceptable salte deraf
NL7712091A (nl) * 1976-11-17 1978-05-19 Merck & Co Inc Werkwijze ter bereiding van een nieuw antibiotisch middel.
US4446146A (en) * 1978-07-26 1984-05-01 Beecham Group Limited β-Lactam containing compounds, their preparation and use
EP0008885B1 (en) * 1978-09-09 1983-11-30 Beecham Group Plc Beta-lactam compounds, their preparation and use
US4530791A (en) * 1979-04-16 1985-07-23 Kowa Co., Ltd. β-Lactam antibiotics
JPS6029668A (ja) * 1983-07-28 1985-02-15 Hino Motors Ltd 経済運転ガイド装置
CN1976747A (zh) * 2004-06-30 2007-06-06 帝斯曼知识产权资产管理有限公司 包含beta－内酰胺抗生素的产品

Also Published As

Publication number Publication date
DE2513854C2 (de) 1984-04-19
LU72155A1 (ja) 1975-08-20
AT345454B (de) 1978-09-25
AU7959975A (en) 1976-09-30
JPS582675B2 (ja) 1983-01-18
BE827332A (fr) 1975-09-29
FR2265399B1 (ja) 1978-08-04
DE2513854A1 (de) 1975-10-02
CH626628A5 (en) 1981-11-30
AU530414B2 (en) 1983-07-14
FR2265399A1 (ja) 1975-10-24
GB1489235A (en) 1977-10-19
CA1050460A (en) 1979-03-13
ATA228475A (de) 1978-01-15
NL7503672A (nl) 1975-09-30
OA05204A (fr) 1981-02-28
SE7503536L (sv) 1975-09-29
AU4549979A (en) 1981-05-14
JPS50140692A (ja) 1975-11-11

Similar Documents

Publication Publication Date Title
AU498050B2 (en) Pallet-container
AU497500B2 (en) Adriamycins
AU497203B2 (en) Neohelometer
AU500773B2 (en) Carbonylaldiminomethanephosphonates
AU497283B2 (en) 1-thiadiazolimidazolidinones
AU499460B2 (en) Antiobotics
AU467292B2 (en) Eye-bush
AU505415B2 (en) Sofabed
AU496973B2 (en) 5-nitro-imidazoles
AU499459B2 (en) Antioboitics
AU503202B2 (en) 3-methylenecepham sulfonides
AU499812B2 (en) Halo-pregnanes
AU504180B2 (en) Hexanhydroindolinols
AU507312B2 (en) 1-aryloxy-4-amino-2-butanols
AU506970B2 (en) 4d-phenyl-decahydroisoquinolines
AU504398B2 (en) Steroidal-3-thiones
AU485931B2 (en) Triazine-diones
AU484632B2 (en) Aryloxyphenylpropylamines
AU487545B2 (en) Handstamp
AU488320B2 (en) Polycycloanilines
AU488592B2 (en) Tapemeasure
AU488720B2 (en) 2-deutero-3-fluoro-alanine
AU483104B2 (en) Dipenylpropylamines
AU493093B2 (en) Pyridobenzodiazepinones
AU482524B2 (en) Pyridoindoles